Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.74 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PREP | P48147 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13099474 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13099473 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL3107219 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13108375 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13099475 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13398345 | 0.93 | ALDH1A1 (0.87) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13398378 | 0.93 | ALDH1A1 (0.87) | ALDH1A1HCRTR1OPRK1L3MBTL1PREP | |
| SCHEMBL13108582 | 0.88 | ALDH1A1 (0.78) | ALDH1A1HCRTR1OPRK1PREPKDM4E | |
| SCHEMBL3264452 | 0.88 | ALDH1A1 (0.78) | ALDH1A1HCRTR1OPRK1PREPKDM4E | |
| SCHEMBL15978272 | 0.88 | ALDH1A1 (0.78) | ALDH1A1HCRTR1OPRK1PREPKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256142-A1 | SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8- CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS | UNIVERSITY OF NORTH CAROLINA | 2010-10-07 | — | — | US | disclosed |
| WO-2010037050-A2 | SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS | UNIVERSITY OF KANSAS (US) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256142-A1 | SYNTHESIS OF FUNCTIONALIZED OCTAHYDRO-ISOQUINOLIN-1-ONE-8- CARBOXAMIDES, OCTAHYDRO-ISOQUINOLIN-1-ONE-8-CARBOXYLIC ESTERS AND ANALOGS, AND THERAPEUTIC METHODS | OPRM1, OPRK1, OPRL1 | ALDH1A1 131/4885HCRTR1 14/4885OPRK1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.